Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NIDA-CTN-0100: Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

NCT04464980 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT04464980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04464980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NIDA-CTN-0100: Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 8, 2021
Completion date
January 31, 2027
Enrollment
1,516 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder (oud)